PCI Biotech: Invitation to first quarter 2021 results presentation
Oslo, Norway, 30 April 2021 – PCI Biotech’s (OSE: PCIB) first quarter 2021 interim report…
Month: April 2021
Audited annual report 2020
New JSC Olainfarm strategy is approved The Company reviewed operations in the main markets JSC…
Biophytis – Second Combined General Meeting to Take Place on May 10, 2021 without the physical presence of its shareholders
PARIS and CAMBRIDGE, Mass., April 30, 2021 (GLOBE NEWSWIRE) — Biophytis SA (Euronext Growth Paris:…
Change in numbers of shares and votes in Saniona AB (publ)
PRESS RELEASE April 30, 2021 During April, the registered number of shares and votes in…
Synairgen announces data from Home Cohort of SG016 Phase II trial of inhaled interferon beta in COVID-19 patients and encouraging combined data for whole SG016 trial
Press release Synairgen plc(‘Synairgen’ or the ‘Company’) Synairgen announces data from Home Cohort of SG016…
Glycotope Announces Poster Presentations at the 2021 American Society of Clinical Oncology (ASCO) Virtual Annual Meeting
Glycotope Announces Poster Presentations at the 2021 American Society of Clinical Oncology (ASCO) Virtual Annual…
Nicox Updates on Fera Pharmaceuticals’ Continuing Evaluation of Naproxcinod
Press Release Nicox Updates on Fera Pharmaceuticals’ Continuing Evaluation of Naproxcinod April 30, 2021 –…
OXURION NV Presenting Scientific Data at ARVO 2021 Annual Meeting
Leuven, BE, Boston, MA, US – April 30st, 2021 – 7.30 AM CET – Oxurion…
miDiagnostics accelerates with launch of rapid COVID-19 PCR test product
miDiagnostics accelerates with launch of rapid COVID-19 PCR test product Additional funding of 58 million…
Werewolf Therapeutics Announces Pricing of Upsized Initial Public Offering
CAMBRIDGE, Mass., April 29, 2021 (GLOBE NEWSWIRE) — Werewolf Therapeutics, Inc. (NASDAQ: HOWL), an innovative…
Appendix 4C Quarterly Activity Report
Mesoblast Operational and Financial Highlights for Quarter Ended March 31, 2021 NEW YORK, April 29,…
COMPASS Pathways announces pricing of public offering
London, UK, 30 April 2021 (GLOBE NEWSWIRE) — COMPASS Pathways plc…
Remestemcel-L Reduces Mortality in Patients Less Than 65 Years Old With Moderate/Severe COVID-19 ARDS: Topline 60-Day Results From Randomized Controlled Trial
Remestemcel-L reduced mortality through 60 days in the pre-specified population under 65 years old In…
Mesoblast Corporate Update
NEW YORK, April 29, 2021 (GLOBE NEWSWIRE) — Mesoblast Limited (Nasdaq:MESO; ASX:MSB), global leader in…
Vaccitech Announces Pricing of Initial Public Offering
OXFORD, United Kingdom, April 29, 2021 (GLOBE NEWSWIRE) — Vaccitech plc (“Vaccitech”) (Nasdaq: VACC), a…
Early Warning Reports Issued Pursuant to National Instrument 62-103 in Connection with the Completion of Private Share Sales
TORONTO, April 29, 2021 (GLOBE NEWSWIRE) — Jack Burnett, President and a director of Ramm…
Pharvaris Reports Full Year 2020 Financial Results and Provides Business Highlights
RAPIDe-1 clinical trial enrolling, evaluating PHVS416 as an oral on-demand therapy for HAE Open IND…
Eloxx Pharmaceuticals Adds Additional Treatment Arm to Ongoing Phase 2 Clinical Studies for Cystic Fibrosis
Fifth Treatment Arm to Evaluate Safety of ELX-02 in Combination with Kalydeco (ivacaftor) Reaffirmed Data…
Selecta Biosciences Announces Three Presentations at the Upcoming 24th Annual Meeting of the American Society of Gene & Cell Therapy (ASGCT)
WATERTOWN, Mass., April 29, 2021 (GLOBE NEWSWIRE) — Selecta Biosciences, Inc. (NASDAQ: SELB), a biotechnology…
Lexicon Pharmaceuticals to Host First Quarter 2021 Financial Results Conference Call and Webcast on May 6, 2021
THE WOODLANDS, Texas, April 29, 2021 (GLOBE NEWSWIRE) — Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX), will…